Asahi Kasei Corporation (AHKSY) stock price, news, quote and history

Asahi Kasei Therapeutics Announces Late-Breaking Oral and Poster Presentations at IDWeek 2026

Asahi Kasei Strengthens Carbon Footprint Transparency for Acrylonitrile Production with Independent Third-Party Verification

A chemical used in plastics and fibers now has independently verified carbon-footprint data.

Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data

FDA approves Asahi Kasei’s Hovilpri for refractory HSV

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements

Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients

Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics

Asahi Kasei Corp's Dividend Analysis

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

Asahi Kasei Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design

Sensors react almost instantly to help detect dangerous electrical arcs

Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy